FDA Updates Standards List for Device Makers
Published Date: 2/19/2026
Notice
Summary
The FDA just updated its official list of standards that medical device makers can use to prove their products are safe and effective. These changes, effective February 19, 2026, help companies speed up the approval process by following clear, recognized rules. If you’re in the medical device world, this means smoother reviews and no surprise costs or delays!
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Updated recognized standards list
The FDA published modifications to its list of recognized consensus standards that are applicable February 19, 2026. You are a medical device manufacturer if you elect to declare conformity with these standards to meet parts of premarket review submissions, and the FDA says the publication will assist those manufacturers in meeting certain device requirements.
Many standards withdrawn and replaced
The notice lists specific recognized consensus standards that the FDA is withdrawing, correcting, revising, or replacing with newer versions (for example, many ISO and ASTM standards across anesthesiology, biocompatibility, cardiovascular, dental, orthopedics, materials, and other device areas). These changes are incorporated under "Recognition List Number: 065" and are applicable February 19, 2026.
Searchable database and ongoing updates
FDA is incorporating these Recognition List Number: 065 modifications into its searchable database (accessible via FDA websites) and states it will announce additional modifications once a year or more often if needed. You can use the searchable database to find the current FDA-recognized consensus standards.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09767 — Oscar Bobo: Final Debarment Order
Oscar Bobo is officially banned for 5 years from importing any drugs into the U.S. because he repeatedly brought in mislabeled medicines that don’t follow FDA rules. He ignored the chance to defend himself, so the ban started on May 15, 2026. This means no drug imports from him for a while, but he can apply to end the ban anytime if he meets FDA’s conditions.
2026-09543 — Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting
The FDA wants your thoughts on how drug companies report problems after their products hit the market. This affects drug makers and healthcare folks who keep track of side effects. They’re asking for comments by July 13, 2026, to help improve the process without adding extra costs or paperwork.
2026-09544 — Modified Risk Tobacco Product Application: Renewal Applications for VLN® King and VLN® Menthol King, Cigarette Products Submitted by 22nd Century Group Inc.
The FDA is inviting the public to comment on the renewal of special approval for two cigarette products by 22nd Century Group Inc. These products claim to lower health risks compared to regular cigarettes. If approved, the renewal keeps these products on the market with their modified risk status, affecting smokers and the tobacco industry starting May 13, 2026.
2026-09448 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3
The FDA is asking for approval to collect info for the third group in its Real Cost Campaign, which teaches kids about the dangers of tobacco. This helps the FDA improve its anti-smoking messages and protect young people’s health. Comments on this info collection are open until June 12, 2026, with no new costs for participants.
2026-09368 — Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization; Guidance for Industry; Availability
The FDA is setting clear rules for certain new tobacco products like e-cigarettes and nicotine pouches that don’t have official approval yet. Companies selling these products without permission might face enforcement actions starting now, so they need to get authorized or risk penalties. This helps protect public health and keeps the market fair and safe.
2026-09335 — Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microorganism Nucleic Acids and Resistance Markers From Patients With Suspected Orthopedic Infection
Hey there! This update is all about a new medical device that helps doctors quickly find germs and their resistance traits in people who might have bone infections. It affects hospitals and labs by officially classifying this device, making it easier and faster to diagnose tough infections. The change kicks in soon, helping patients get the right treatment without delay—and it could save money by avoiding wrong meds!
Previous / Next Documents
Previous: 2026-03309 — Indian Energy Service Center; Receipt of Tribal Energy Resource Agreement for the Southern Ute Indian Tribe of the Southern Ute Reservation, Colorado
The Southern Ute Indian Tribe in Colorado has submitted a Tribal Energy Resource Agreement (TERA) that lets them manage energy projects on their land without needing extra government approval. The Department of the Interior is reviewing this agreement and wants public comments by March 23, 2026. If approved, this will speed up energy deals and give the Tribe more control over their resources.
Next: 2026-03311 — Agency Information Collection Activities; Proposed Collection; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products
The FDA wants your thoughts on how they collect info about safely processing and importing fish and seafood. This affects businesses that handle fish products, aiming to keep seafood safe and clean. You’ve got until April 20, 2026, to share your comments—no fees, just your voice helping shape safer seafood rules!